A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19 - Concepedia

Concepedia

Publication | Open Access

A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19

DOI Full Paper Access

24

Citations

27

References

2022

Year

Luigi Aurisicchio, Nadia Brambilla, Marina Elena Cazzaniga, Paolo Bonfanti, Stefano Milleri, Paolo A. Ascierto, Serena Capici, Cristina Vitalini, Federica Girolami, Giampaolo Giacovelli,

Molecular Therapy

References

	Year	Citations

Page 1